retatrutide clinical trials trial done! Now onto Zep! : r/Zepbound Retatrutide Clinical Trial

M., Krishnan, B

In November 2023, the FDA granted approval for Zepbound (tirzepatide) for chronic weight management in adults with obesity (body mass index 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease

She was initially concerned that the side effects were affecting her child's growth

Symptoms may include: Visible abdominal distension A feeling of pressure or fullness Core weakness or instability Pelvic pressure or discomfort This is where a whole body, pelvic health approach becomes important

L--glutamyl-L-cysteinyl-glycine) with concentrations in the millimolar range [6]

Introduction Non-alcoholic fatty liver disease (NAFLD) is defined as fat accumulation in more than 5% of the hepatocytes